Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of CureVac, SB-FIX, SB-318, SB-913 of In-Cell-Art. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA mRNA Vaccines and Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA mRNA Vaccines and Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by mRNA Vaccines and Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Tiba Biotechnology
BioNTech
Translate Bio
Argos Therapeutics
In-Cell-Art
CureVac
eTheRNA
Sangamo Therapeutics
Ethris
Moderna Therapeutics
By Type:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User:
Infectious Disease
Cancer
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines and Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2016 to 2027
-
1.3.2 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2016 to 2027
-
1.3.3 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2016 to 2027
-
1.3.4 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease from 2016 to 2027
-
1.4.2 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.3 USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of mRNA Vaccines and Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of mRNA Vaccines and Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine
-
3.4.2 Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
-
3.4.3 Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
-
3.4.4 Market Size and Growth Rate of Infection Prevention MRNA Vaccine
4 Segmentation of mRNA Vaccines and Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of mRNA Vaccines and Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of mRNA Vaccines and Therapeutics in Infectious Disease
-
4.4.2 Market Size and Growth Rate of mRNA Vaccines and Therapeutics in Cancer
-
4.4.3 Market Size and Growth Rate of mRNA Vaccines and Therapeutics in Other
5 Market Analysis by Regions
-
5.1 USA mRNA Vaccines and Therapeutics Production Analysis by Regions
-
5.2 USA mRNA Vaccines and Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA mRNA Vaccines and Therapeutics Landscape Analysis
-
6.1 West USA mRNA Vaccines and Therapeutics Landscape Analysis by Major Types
-
6.2 West USA mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users
7 South USA mRNA Vaccines and Therapeutics Landscape Analysis
-
7.1 South USA mRNA Vaccines and Therapeutics Landscape Analysis by Major Types
-
7.2 South USA mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA mRNA Vaccines and Therapeutics Landscape Analysis
-
8.1 Middle West USA mRNA Vaccines and Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA mRNA Vaccines and Therapeutics Landscape Analysis
-
9.1 Northeast USA mRNA Vaccines and Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Tiba Biotechnology
-
10.1.1 Tiba Biotechnology Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 BioNTech
-
10.2.1 BioNTech Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Translate Bio
-
10.3.1 Translate Bio Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Argos Therapeutics
-
10.4.1 Argos Therapeutics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 In-Cell-Art
-
10.5.1 In-Cell-Art Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 CureVac
-
10.6.1 CureVac Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 eTheRNA
-
10.7.1 eTheRNA Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sangamo Therapeutics
-
10.8.1 Sangamo Therapeutics Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Ethris
-
10.9.1 Ethris Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Moderna Therapeutics
-
10.10.1 Moderna Therapeutics Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2016 to 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2016 to 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2016 to 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease from 2016 to 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of mRNA Vaccines and Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of mRNA Vaccines and Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of mRNA Vaccines and Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of mRNA Vaccines and Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of mRNA Vaccines and Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of mRNA Vaccines and Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Infectious Disease
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Other
-
Table USA mRNA Vaccines and Therapeutics Production by Regions
-
Table USA mRNA Vaccines and Therapeutics Production Share by Regions
-
Figure USA mRNA Vaccines and Therapeutics Production Share by Regions in 2016
-
Figure USA mRNA Vaccines and Therapeutics Production Share by Regions in 2021
-
Figure USA mRNA Vaccines and Therapeutics Production Share by Regions in 2027
-
Table USA mRNA Vaccines and Therapeutics Consumption by Regions
-
Table USA mRNA Vaccines and Therapeutics Consumption Share by Regions
-
Figure USA mRNA Vaccines and Therapeutics Consumption Share by Regions in 2016
-
Figure USA mRNA Vaccines and Therapeutics Consumption Share by Regions in 2021
-
Figure USA mRNA Vaccines and Therapeutics Consumption Share by Regions in 2027
-
Table West USA mRNA Vaccines and Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA mRNA Vaccines and Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2016
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2021
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2027
-
Table West USA mRNA Vaccines and Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2027
-
Table South USA mRNA Vaccines and Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA mRNA Vaccines and Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2016
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2021
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2027
-
Table South USA mRNA Vaccines and Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA mRNA Vaccines and Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA mRNA Vaccines and Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA mRNA Vaccines and Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA mRNA Vaccines and Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA mRNA Vaccines and Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA mRNA Vaccines and Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Tiba Biotechnology
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiba Biotechnology
-
Figure Sales and Growth Rate Analysis of Tiba Biotechnology
-
Figure Revenue and Market Share Analysis of Tiba Biotechnology
-
Table Product and Service Introduction of Tiba Biotechnology
-
Table Company Profile and Development Status of BioNTech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech
-
Figure Sales and Growth Rate Analysis of BioNTech
-
Figure Revenue and Market Share Analysis of BioNTech
-
Table Product and Service Introduction of BioNTech
-
Table Company Profile and Development Status of Translate Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translate Bio
-
Figure Sales and Growth Rate Analysis of Translate Bio
-
Figure Revenue and Market Share Analysis of Translate Bio
-
Table Product and Service Introduction of Translate Bio
-
Table Company Profile and Development Status of Argos Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics
-
Figure Sales and Growth Rate Analysis of Argos Therapeutics
-
Figure Revenue and Market Share Analysis of Argos Therapeutics
-
Table Product and Service Introduction of Argos Therapeutics
-
Table Company Profile and Development Status of In-Cell-Art
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art
-
Figure Sales and Growth Rate Analysis of In-Cell-Art
-
Figure Revenue and Market Share Analysis of In-Cell-Art
-
Table Product and Service Introduction of In-Cell-Art
-
Table Company Profile and Development Status of CureVac
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac
-
Figure Sales and Growth Rate Analysis of CureVac
-
Figure Revenue and Market Share Analysis of CureVac
-
Table Product and Service Introduction of CureVac
-
Table Company Profile and Development Status of eTheRNA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA
-
Figure Sales and Growth Rate Analysis of eTheRNA
-
Figure Revenue and Market Share Analysis of eTheRNA
-
Table Product and Service Introduction of eTheRNA
-
Table Company Profile and Development Status of Sangamo Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics
-
Figure Sales and Growth Rate Analysis of Sangamo Therapeutics
-
Figure Revenue and Market Share Analysis of Sangamo Therapeutics
-
Table Product and Service Introduction of Sangamo Therapeutics
-
Table Company Profile and Development Status of Ethris
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris
-
Figure Sales and Growth Rate Analysis of Ethris
-
Figure Revenue and Market Share Analysis of Ethris
-
Table Product and Service Introduction of Ethris
-
Table Company Profile and Development Status of Moderna Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics
-
Figure Sales and Growth Rate Analysis of Moderna Therapeutics
-
Figure Revenue and Market Share Analysis of Moderna Therapeutics
-
Table Product and Service Introduction of Moderna Therapeutics
-
